Highlights
- 1Science advances · 2026
Publications
125 publications
Funding
7 grantsView NIH portfolio on RePORTER ↗
Active
3 grants- PIU01FD008983-01High-specificity genome-scale cell surface proteomics for discovery of tumor-specific cancer therapeutic targetsNIH · 2026–2029 · via NIH RePORTER
- PIU01FD008299-01Integrative proteogenomics for elucidation of tumor-specific cell surface proteomes in ultra-rare cancersNIH · 2024–2027 · via NIH RePORTER
Completed grants (4)
- PIR01CA214812-05Structure and function of genome plasticity in human cancerNCI · 2017–2023 · via NIH RePORTER
- PIR21CA235285-03Multi-dimensional targeted mass spectrometry technology for pathway-scale functional proteomicsNCI · 2019–2023 · via NIH RePORTER
- PIR21CA188881-02Phosphoproteomic signatures for early detection and stratification of AMLNCI · 2015–2018 · via NIH RePORTER
- PIK08CA160660-05Aberrant activation of HGF/MET signaling as a therapeutic target in AMLNCI · 2011–2016 · via NIH RePORTER
News mentions
1 mentionView all WCM news ↗
- New Starr Cancer Consortium Grants Awarded to Weill Cornell Medicine ResearchersOctober 30, 2024
Three teams led by Weill Cornell Medicine scientists have received awards from the Starr Cancer Consortium in its 17th and final annual grant competition
Mentoring
7 menteesAll publications with mentees →
- SCShuyuan ChengCell & Developmental Biology (PhD) · Class of 2026
- NKNathaniel KwokMD mentee · Class of 2022
- ZSZheng SerTri-I Program in Chemical Biology (PhD) · Class of 2020
- LMLauren MarekPharmacology (PhD) · Class of 2019
- ABAlexander BangMD mentee · Class of 2024
- JKJeremy KaplittMD mentee · Class of 2023
- AAAnna AntonovaPharmacology (PhD)